|Former Common name||No Data|
|Genotype||cc Myeloma high incidence H2|
|Strain development||NIH to Instit. Genetics (Mishima) at F230+8 in 1984 .
Developed by H. Bagg in 1913, transferred to MacDowell, to Snell in 1932. Also widely distributed as By, AnN, HeA and AnPt substrains. An: H. B. Andervont. N: NIH.
|Strain description||One of the most widely used inbred strains. Useful for the production of monoclonal antibodies. Widely used in other general purposes.|
|Colony maintenance||Good breeding performance.|
|Symbol name||No Data|
|Common name||No Data|
|Symbol description||No Data|
|Research applications||No Data|
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE.
|1||Mouse of the Month Jan 2009|
|Depositor||Shiroishi, Toshihiko (National Institute of Genetics)|
|Strain Status /